ライフサイエンスコーパス: leg pain

1 te or chronic low back pain (with or without leg pain).

2 lation for the treatment of chronic back and leg pain.

3 extremities and are a rare cause of chronic leg pain.

4 e patients present with non-specific chronic leg pain.

5 often a challenging option for patients with leg pain.

6 long duration of LBP episodes, and radiating leg pain.

7 eported LBP only and 21.3% reported LBP plus leg pain.

8 the low back or leg, LBP only, and LBP with leg pain.

9 es were independent correlates of exertional leg pain.

10 ere all significant correlates of exertional leg pain.

11 audication Questionnaire assessed exertional leg pain.

12 ercent of PAD participants had no exertional leg pain.

13 rior to open microdiscectomy in reduction of leg pain.

14 I], -2.1 to 0.1; P=0.07) or the intensity of leg pain (adjusted difference in the average treatment e

15 adaches but more difficulty with walking and leg pain (all p < 0.05).

16 d injections offer only short-term relief of leg pain and disability for patients with sciatica.

17 ntral spinal stenosis and moderate-to-severe leg pain and disability to receive epidural injections o

18 Nine female patients with leg pain and imaging features indicative of intramedulla

19 n subjects with chronic low back pain and/or leg pain and performed post hoc analysis on changes in o

20 ral corticosteroid injections are useful for leg pain and sensory deficits early in the course of sci

21 y healthy 41-year-old man presents with left leg pain and shortness of breath.

22 m baseline, PCDT led to greater reduction in leg pain and swelling ( P<0.01 for comparisons at 10 and

23 6 months or later using Ginsberg's criteria (leg pain and swelling of >/=1 month duration).

24 erential diagnosis in a patient with chronic leg pain and swelling.

25 ineteen patients with activity-related lower leg pain and tenderness on palpation along the posterome

26 ld man presented with progressive asymmetric leg pain and weakness.

27 t is effective for back pain with or without leg pain, and conflicting evidence that it can prevent m

28 e on the Oswestry Disability Index, back and leg pain, and quality-of-life scores at 6 weeks, 3 month

29 % of patients reported that their back pain, leg pain, and walking were worse.

30 nt as intermittent claudication and atypical leg pain, and, in more severe cases, ischemic rest pain,

31 was to determine whether LBP and concurrent leg pain are associated with health-related quality of l

32 Chronic pain, including chronic low back and leg pain are prominent causes of disability worldwide.

33 reduction of 50% or more in overall back and leg pain assessed at 3 and 12 months (previously publish

34 id not significantly reduce the intensity of leg pain associated with sciatica and did not significan

35 Leg pain, back pain, and disability were converted to co

36 in more favourable results for self-reported leg pain, back pain, functional status, quality of life,

37 Back-related leg pain (BRLP) is often disabling and costly, and there

38 th IC, participants with atypical exertional leg pain/carry on achieved a greater distance on the 6-m

39 The atypical exertional leg pain/carry on group (exertional leg pain other than

40 2% of children had early symptoms of sepsis (leg pains, cold hands and feet, abnormal skin colour) th

41 The tool included 9 items: referred leg pain, comorbid pain, disability (2 items), bothersom

42 oes not develop the symptoms of back pain or leg pain during the injection.

43 articipants who never experienced exertional leg pain, even during the 6-minute walk; n=72).

44 n established treatment for chronic back and leg pain for more than 50 years; however, outcomes are v

45 Approximately 75% of the patients had leg pain for more than a year, and more than 80% had bac

46 Participants with LBP and LBP plus leg pain had lower scores in all SF-36 domains, reflecti

47 ain improvement of 2 or more points, and NRS leg pain improvement of 4 or more points.

48 exertional leg pain/inactive (no exertional leg pain in individual who walks </=6 blocks per week [n

49 revalent and disabling cause of low back and leg pain in older persons, affecting an estimated 103 mi

50 steroid injections compared with placebo for leg pain in the short term (mean difference, -6.2 [95% C

51 The group without exertional leg pain/inactive (no exertional leg pain in individual

52 The differential diagnosis of exertional leg pain includes stress fractures, stress reaction, per

53 The primary outcome of the leg-pain intensity score at 6 months was 2.8 in the surg

54 The primary outcome was the leg-pain intensity score on a 10-point scale (with 0 ind

55 At week 52, the mean unadjusted leg-pain intensity score was 3.4 in the pregabalin group

56 At week 8, the mean unadjusted leg-pain intensity score was 3.7 in the pregabalin group

57 d 10 the worst possible pain) at week 8; the leg-pain intensity score was also evaluated at week 52,

58 At baseline, the mean score for leg-pain intensity was 7.7 in the surgical group and 8.0

59 Although exertional leg pain is a hallmark of peripheral arterial disease (P

60 cause of acute low back pain with radiating leg pain is lumbar disc herniation.

61 Among participants without exertional leg pain, lower ABI levels were associated with slower w

62 1-9.9), the presence of bilateral buttock or leg pain (LR, 6.3; 95% CI, 3.1-13), and neurogenic claud

63 patients with malignancy and/or preoperative leg pain may be at increased risk for poor QoL after sur

64 The primary outcome was self-reported leg pain measured by a 0-100 visual analogue scale at 12

65 cantly lower visual analogue scale score for leg pain (median 7.0, interquartile range 1.0-30.0) comp

66 ther than IC associated with walking through leg pain [n = 41]) and the atypical exertional leg pain/

67 uppression, fatigue, neurotoxicity, rash, or leg pain) necessitating dose reduction (n = 4) or discon

68 te analysis identified a higher preoperative leg pain (odds ratio: 1.2) and the presence of a maligna

69 ude the chest pain of a heart attack and the leg pain of a 30 s sprint--occurs when muscle gets too l

70 33% (ODI), 27% (NRS back pain), and 31% (NRS leg pain) of the patients.

71 udication Questionnaire (ZCQ), back pain and leg pain on a 10-point numeric rating score (NRS), patie

72 The primary outcome was the intensity of leg pain on a visual analogue scale (ranging from 0 to 1

73 Participants in the group with leg pain on exertion and rest (n = 88) had a higher (poo

74 ticipants without PAD, PAD participants with leg pain on exertion and rest at baseline had greater me

75 walks </=6 blocks per week [n = 28]) and the leg pain on exertion and rest group had poorer functioni

76 sability) and the rating of the intensity of leg pain (on a scale from 0 to 10, with 0 indicating no

77 on, and adverse events as well as changes in leg pain, Oswestry Disability Index, and health-related

78 ertional leg pain/carry on group (exertional leg pain other than IC associated with walking through l

79 l exertional leg pain/stop group (exertional leg pain other than IC that causes one to stop walking [

80 arthritis, diabetes mellitus, stroke, upper leg pain, peripheral vascular disease, left ventricular

81 , pre-surgical score on the exercise-induced leg pain questionnaire, time from initial presentation t

82 andidates with chronic, intractable back and leg pain refractory to conservative therapy, who consent

83 PRIMARY OUTCOME: back or leg pain-related disability measured by the modified Rol

84 dural steroids (75%) reported 50% or greater leg pain relief and a positive global perceived effect a

85 The primary outcome was leg pain severity, as assessed with the numeric rating s

86 Scores for leg pain severity, Oswestry Disability Index, and health

87 For leg pain, SMT plus HEA had a clinically important advant

88 g pain [n = 41]) and the atypical exertional leg pain/stop group (exertional leg pain other than IC t

89 lderly patients, despite less improvement of leg pain than with fusion surgery.

90 The main clinical feature is recurrent leg pain that progresses to constant painful paraesthesi

91 te or chronic low back pain (with or without leg pain) that reported pain outcomes, back-specific fun

92 estimate, 0.77; 95% CI, 0.75-0.79); for NRS leg pain, the C statistic ranged from 0.74 to 0.77 (pool

93 d high-normal ABIs appeared to have ischemic leg pain; thus, a "normal ABI" is likely to range from 1

94 age, sex, body mass index, absence of whole leg pain, traumatic onset, difficulty descending stairs,

95 Patient-reported back and leg pain using the visual analog scale (VAS) and opioid

96 ibility criteria included overall, back, and leg pain visual analog scale score of 60 mm or more; Osw

97 LBP plus leg pain was associated with difficulty in social intera

98 No category of exertional leg pain was sufficiently sensitive or specific for rout

99 LBP and LBP plus leg pain were associated with 2-fold greater odds of fal

100 d treatments for adults with chronic back or leg pain who had not previously used SCS.

101 cal classification >=3, or at least moderate leg pain with a Venous Clinical Severity Score of 2 or g

102 reduction of 50% or more in overall back and leg pain with no increase in pain medications.